EcoDrugPlus

Ensembl ID : ML043315a
Gene Symbol: -
External references: -
117 Possible Orthologues:

Ensembl ID : ML04333a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML04345a
Gene Symbol: -
External references: -
65 Possible Orthologues:

Ensembl ID : ML043814a
Gene Symbol: -
External references: -
167 Possible Orthologues:

Ensembl ID : ML043816a
Gene Symbol: -
External references: -
167 Possible Orthologues:

Ensembl ID : ML04412a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML044613a
Gene Symbol: -
External references: -
120 Possible Orthologues:

Ensembl ID : ML045244a
Gene Symbol: -
External references: -
304 Possible Orthologues:

Ensembl ID : ML045246a
Gene Symbol: -
External references: -
67 Possible Orthologues:

Ensembl ID : ML046334a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML046516a
Gene Symbol: -
External references: -
113 Possible Orthologues:

Ensembl ID : ML050915a
Gene Symbol: -
External references: -
47 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).